Ptc Therapeutics (PTCT) FCF Margin (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly FCF Margin of 35.21% for Q2 2026, up 6851.0% year-over-year from 0.51% in Q2 2025, and up 259.29% quarter-over-quarter from 22.1% in Q1 2026.
Ptc Therapeutics (PTCT) FCF Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' FCF Margin history runs 15 years deep, the most recent figure standing at 35.21% for Q2 2026.
- In Q2 2026, FCF Margin rose 6851.0% year-over-year to 35.21%; the TTM figure through Jun 2026 stood at 3.94% (down 4346.0% YoY), while the FY2025 annual figure was 40.58%, up 5474.0% from the prior year.
- FCF Margin for Q2 2026 stood at 35.21%, up from 22.1% in the prior quarter.
- The five-year high for FCF Margin was 73.84% in Q1 2025, with the low at 104.28% in Q4 2022.
- The 5-year median for FCF Margin is 22.1% (2026), against an average of 19.71%.
- The sharpest annual moves came in 2023 and 2026: FCF Margin jumped 6981 bps in 2023, then slumped 9594 bps in 2026.
- Ptc Therapeutics' FCF Margin stood at 104.28% in 2022, then soared by 67 bps to 34.47% in 2023, then surged by 54 bps to 15.84% in 2024, then slumped by 40 bps to 22.25% in 2025, then soared by 258 bps to 35.21% in 2026.
- Business Quant data shows PTCT's FCF Margin at 35.21% in Q2 2026, 22.1% in Q1 2026, and 22.25% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 35.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.21% |
| Mar 31, 2026 | -22.10% |
| Dec 31, 2025 | -16.95% |
| Sep 30, 2025 | -33.05% |
| Jun 30, 2025 | -33.35% |
| Mar 31, 2025 | 73.84% |
| Dec 31, 2024 | -12.82% |
| Sep 30, 2024 | -39.39% |
| Mar 31, 2024 | 29.11% |
| Dec 31, 2023 | -34.47% |
| Sep 30, 2023 | -10.62% |
| Jun 30, 2023 | -14.32% |
| Mar 31, 2023 | -13.39% |
| Dec 31, 2022 | -85.34% |
| Sep 30, 2022 | -20.00% |
| Jun 30, 2022 | -38.63% |
| Mar 31, 2022 | -71.75% |
| Dec 31, 2021 | -46.94% |
| Sep 30, 2021 | -41.11% |
| Jun 30, 2021 | -33.53% |